Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis
Authors
Keywords
BCNU, Carmustine, Gliadel, Glioblastoma, Glioma, High-grade, Meta-analysis, Wafer
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 122, Issue 2, Pages 367-382
Publisher
Springer Nature
Online
2015-01-29
DOI
10.1007/s11060-015-1724-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of post-operative complications associated with repeat resection and BCNU wafer implantation in recurrent glioblastoma
- (2013) Maria Angela Samis Zella et al. ACTA NEUROCHIRURGICA
- Delayed post-operative haemorrhage after carmustine wafer implantation: A case series from two UK centres
- (2013) Rahul Surendra Shah et al. BRITISH JOURNAL OF NEUROSURGERY
- MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers
- (2013) A. Gutenberg et al. BRITISH JOURNAL OF NEUROSURGERY
- The role of Gliadel wafers in the treatment of high-grade gliomas
- (2013) Amade Bregy et al. Expert Review of Anticancer Therapy
- The combination of carmustine wafers and temozolomide for the treatment of malignant gliomas. A comprehensive review of the rationale and clinical experience
- (2013) A. Gutenberg et al. JOURNAL OF NEURO-ONCOLOGY
- Prospective study of carmustine wafers in combination with 6-month metronomic temozolomide and radiation therapy in newly diagnosed glioblastoma: preliminary results
- (2013) Andrea Salmaggi et al. JOURNAL OF NEUROSURGERY
- A Multicenter Phase I/II Study of the BCNU Implant (Gliadel® Wafer) for Japanese Patients with Malignant Gliomas
- (2013) Tomokazu AOKI et al. NEUROLOGIA MEDICO-CHIRURGICA
- IDH1 mutation is associated with improved overall survival in patients with glioblastoma: a meta-analysis
- (2013) Hong-Bin Cheng et al. TUMOR BIOLOGY
- Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma
- (2012) Pasquale De Bonis et al. ACTA NEUROCHIRURGICA
- Implanted Carmustine Wafers Followed by Concomitant Radiochemotherapy to Treat Newly Diagnosed Malignant Gliomas: Prospective, Observational, Multicenter Study on 92 Cases
- (2012) Julien Duntze et al. ANNALS OF SURGICAL ONCOLOGY
- The effects of the NICE Technology Appraisal 121 (Gliadel and Temozolomide) on survival in high-grade glioma
- (2012) James Geoffrey Barr et al. BRITISH JOURNAL OF NEUROSURGERY
- O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy w
- (2012) Emmanuèle Lechapt-Zalcman et al. CANCER
- Impact of the per-operatory application of GLIADEL wafers (BCNU, carmustine) in combination with temozolomide and radiotherapy in patients with glioblastoma multiforme: Efficacy and toxicity
- (2012) Petra Miglierini et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Temporal changes in magnetic resonance imaging characteristics of Gliadel wafers and of the adjacent brain parenchyma
- (2012) S. Ulmer et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009
- (2012) T. A. Dolecek et al. NEURO-ONCOLOGY
- The Role of BCNU Polymer Wafers (Gliadel) in the Treatment of Malignant Glioma
- (2012) Seema Nagpal NEUROSURGERY CLINICS OF NORTH AMERICA
- Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis
- (2011) Gregorio Catalán-Uribarrena et al. ACTA NEUROCHIRURGICA
- The sequential use of carmustine wafers (Gliadel®) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review
- (2011) Sanjay Dixit et al. BRITISH JOURNAL OF NEUROSURGERY
- Carmustine-impregnated wafers and their impact in the management of high-grade glioma
- (2011) Renato V La Rocca et al. EXPERT OPINION ON PHARMACOTHERAPY
- Retrospective Comparison of Chemoradiotherapy Followed by Adjuvant Chemotherapy, With or Without Prior Gliadel Implantation (Carmustine) After Initial Surgery in Patients With Newly Diagnosed High-Grade Gliomas
- (2011) Georges Noël et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Space-occupying cyst development in the resection cavity of malignant gliomas following Gliadel® implantation – incidence, therapeutic strategies, and outcome
- (2011) Lutz Dörner et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Postoperative seizure in high grade glioma patients treated with BCNU wafers. A mono-institutional experience
- (2011) Alessandro Della Puppa et al. JOURNAL OF NEURO-ONCOLOGY
- The efficacy of carmustine wafers for older patients with glioblastoma multiforme: prolonging survival
- (2011) Kaisorn L Chaichana et al. NEUROLOGICAL RESEARCH
- The first 3 months after BCNU wafers implantation in high-grade glioma patients: clinical and radiological considerations on a clinical series
- (2010) Alessandro Della Puppa et al. ACTA NEUROCHIRURGICA
- High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) R. Stupp et al. ANNALS OF ONCOLOGY
- Biodegradable Carmustine Wafers (Gliadel) Alone or in Combination with Chemoradiotherapy: The French Experience
- (2010) Philippe Menei et al. ANNALS OF SURGICAL ONCOLOGY
- Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma
- (2010) S. Kunwar et al. NEURO-ONCOLOGY
- First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience
- (2010) Hans Christoph Bock et al. NEUROSURGICAL REVIEW
- Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation
- (2009) Philippe Metellus et al. CANCER
- Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma
- (2009) Alba A. Brandes et al. CANCER
- Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy
- (2009) Mary Lou Affronti et al. CANCER
- Phase II Trial of Gliadel plus O6-Benzylguanine in Adults with Recurrent Glioblastoma Multiforme
- (2009) J. A. Quinn et al. CLINICAL CANCER RESEARCH
- Use of Gliadel (BCNU) Wafer in the Surgical Treatment of Malignant Glioma: A 10-Year Institutional Experience
- (2008) Frank J. Attenello et al. ANNALS OF SURGICAL ONCOLOGY
- Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience
- (2008) Michael Sabel et al. CURRENT MEDICAL RESEARCH AND OPINION
- Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma multiforme
- (2008) Camilo E. Fadul et al. JOURNAL OF NEURO-ONCOLOGY
- A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients
- (2008) Edward Pan et al. JOURNAL OF NEURO-ONCOLOGY
- Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme
- (2008) Borimir J. Darakchiev et al. JOURNAL OF NEUROSURGERY
- Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme
- (2008) Matthew J. McGirt et al. JOURNAL OF NEUROSURGERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started